Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Medinoi Medical Technology (Suzhou) Co., Ltd. is a specialized medical device company focused on the development of neurointerventional and cardiovascular intervention products. Established in 2021 and headquartered in the Suzhou Industrial Park, the company focuses on addressing unmet needs in the treatment of stroke and other vascular disorders. Its product portfolio includes intracranial aspiration catheters, distal access catheters, and microcatheters, with several products having received NMPA approval for commercial use in China. Medinoi leverages advanced manufacturing capabilities to produce high-precision interventional tools designed to improve clinical outcomes in minimally invasive surgeries. The company is backed by prominent venture capital firms, including Sequoia China and GL Ventures, supporting its rapid growth and clinical development. Medinoi aims to become a leading provider of comprehensive solutions for vascular intervention, combining innovative design with high-quality production standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on 苏州迈得诺意医疗技术.